Autoinflammatory & rare systemic diseases
EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update
Methodological detailsguideline update, Agreement obtained through a Delphi survey, Multidisciplinary panel from the Eastern Mediterranean area and Europe, incl. 2 methodologists and 2 patient representatives, Several systematic reviews on pharmacological treatment of FMF and its complications
- Guideline update
- Agreement obtained through a Delphi survey
- Multidisciplinary panel from the Eastern Mediterranean area and Europe, incl. 2 methodologists and 2 patient representatives
- Several systematic reviews on pharmacological treatment of FMF and its complications
Scope
As issued by the authors
Treatment and follow-up of patients with FMF; 4 overarching principles and 12 recommendations, each with degree of agreement (0-10), level of evidence and rationale; agreement greater than 9/10 in all instances
Original publication
EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update. Ann Rheum Dis. Published 9 April 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →